Sei Investments CO Aerie Pharmaceuticals Inc Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $7,319 - $17,499	1,149 Added 2.4%	49,059 $743,000
Q2 2022 Aug 15, 2022	BUY	$4.95 - $9.16 $7,553 - $13,978	1,526 Added 3.29%	47,910 $353,000
Q1 2022 May 13, 2022	BUY	$5.64 - $9.8 $95,394 - $165,757	16,914 Added 57.39%	46,384 $415,000
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $10,733 - $20,381	-1,529 Reduced 4.93%	29,470 $201,000
Q3 2021 Nov 12, 2021	BUY	$11.32 - $16.63 $8,874 - $13,037	784 Added 2.59%	30,999 $345,000

Q2 2021 Aug 06, 2021	BUY	$15.16 - $18.97 $32,791 - $41,032	2,163 Added 7.71%	30,215 $479,000
Q1 2021 May 12, 2021	BUY	$13.12 - $20.9 $34,728 - $55,322	2,647 Added 10.42%	28,052 $492,000
Q4 2020 Feb 08, 2021	BUY	$9.12 - $14.49 $20,492 - $32,559	2,247 Added 9.7%	25,405 $338,000
Q3 2020 Nov 06, 2020	SELL	$10.46 - $14.46 $578,302 - $799,450	-55,287 Reduced 70.48%	23,158 $271,000
Q2 2020 Aug 17, 2020	BUY	$12.0 - $16.13 $367,656 - $494,190	30,638 Added 64.09%	78,445 $1.16 Million
Q2 2020 Aug 11, 2020	SELL	$12.0 - $16.13 $304,728 - $409,605	-25,394 Reduced 34.69%	47,807 $1.15 Million
Q1 2020 May 14, 2020	BUY	$11.84 - $25.52 $299,895 - $646,396	25,329 Added 52.91%	73,201 $986,000
Q4 2019 Feb 06, 2020	BUY	$17.72 - $25.1 $848,291 - $1.2 Million	47,872 New	47,872 $1.16 Million
Q3 2019 Nov 12, 2019	SELL	$18.41 - $28.0 $130,379 - $198,296	-7,082 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $74,597 - $124,140	2,575 Added 57.13%	7,082 $207,000
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $518,940 - $703,684	-14,288 Reduced 76.02%	4,507 $213,000
Q4 2018 Feb 13, 2019	BUY	$33.0 - $60.04 $428,406 - $779,439	12,982 Added 223.33%	18,795 $825,000
Q3 2018 Nov 08, 2018	BUY	$56.15 - $73.9 $56,150 - $73,900	1,000 Added 20.78%	5,813 $359,000
Q2 2018 Aug 03, 2018	SELL	$47.85 - $70.45 $5,311 - $7,819	-111 Reduced 2.25%	4,813 $325,000
Q1 2018 May 11, 2018	BUY	$51.15 - $61.0 $40,101 - $47,824	784 Added 18.94%	4,924 $267,000
Q4 2017 Feb 08, 2018	BUY	$50.85 - $65.1 $52,629 - $67,378	1,035 Added 33.33%	4,140 $247,000
Q3 2017 Nov 06, 2017	BUY	$48.6 - $60.1 $150,903 - $186,610	3,105	3,105 $151,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account